Study designs: all MPD measure sets of study design type replic

replic = replication often for control purposes

Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Cheverud1 17814 body weight (none) pre-weaning (1-3 wks) growth rate   [g/wk]     control group    high-fat diet group LGXSM w/par 16 both 1-3wks N=9 2004
    Gershenfeld1 16201 tail suspension test (none) TST duration of immobility, effect of saline injection on control group   [s]     before injection    after injection inbred 12 m 5-10wks N=5 2003
    Metten2 19501 body weight (none) body weight   [g]     start    Δchange after testing inbred 15 m 8-15wks N=20 2005
    Morgan1 52601 body weight (none) starting body weight   [g]     control group    treatment group inbred w/CC8 9 f 8wks N=4 2014
    Schughart3 57101 body weight (none) body weight pre-infection   [g]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Schughart4 58701 body weight (none) body weight pre-infection   [g]     control group    treated group inbred w/CC8 8 f 8-12wks N=13 2016
    Schughart5 58801 body weight (none) body weight pre-infection   [g]     control group    treated group inbred w/CC8 8 f 8-12wks N=8 2016
    All boxes